Tumour Antigen Choice - Research team

  • Gavin Bendle is focussed on developing TCR gene transfer approaches to treat haematological malignancies, including in particular multiple myeloma.

    FIND OUT MORE

    Dr Gavin Bendle

  • Professor Roy Bicknell is focussed on understanding and therapeutically targeting tumour angiogenesis.

    FIND OUT MORE

    Professor Roy Bicknell

  • David Briggs is a Consultant Clinical Scientist, and head of Histocompatibility and Immunogenetics at NHS Blood and Transplant, Birmingham. He

    FIND OUT MORE

    Professor David Briggs

  • Mark Cobbold is identifying and characterising the immune response to phosphopeptides, an emerging group of tumour-associated antigens. In addition, his work

    FIND OUT MORELinkedin

    Dr Mark Cobbold

  • Charlie Craddock is working with Dr Ram Malladi and Professor Paul Moss on clinical treatment of haematological malignancies, key approaches being

    FIND OUT MORE

    Professor Charlie Craddock

  • Dr Sylvie Freeman is a Clinical Senior Lecturer and Honorary Consultant Haematologist in the departments of Clinical Immunology, University of Birmingham

    FIND OUT MORE

    Dr Sylvie Freeman

  • Dr Andrew Hislop is a viral immunologist with an interest in how T-cells control oncogenic human viruses such as Kaposi sarcoma-associated

    FIND OUT MORE

    Dr Andrew Hislop

  • Dr Steven Lee is a Senior Research Fellow whose research is focused on engineering T cells to target human tumours, either

    FIND OUT MORE

    Dr Steven Lee

  • Dr Heather Long’s research is focused on developing immune T cell-based therapies for the treatment of EBV-associated and non-virus associated lymphomas.

    FIND OUT MORE

    Dr Heather Long

  • Ram Malladi is a consultant haematologist based at the Centre for Clinical Haematology, who works closely with Professor Charlie Craddock and

    FIND OUT MORE

    Dr Ram Malladi

  • Dr Fiyaz Mohammed is a protein crystallographer with a long standing interest in immune receptor structure and function.

    FIND OUT MORE

    Dr Fiyaz Mohammed

  • Professor Moss’s research is focussed around the application of translational immunological research in the study of human cancer.

    FIND OUT MORE

    Professor Paul Moss

  • Professor Ben Willcox is characterising the immune response to cellular stress antigens, including targets recognised by gamma delta T cells,

    FIND OUT MORE

    Professor Ben Willcox

  • Dr Carrie Willcox is an immunologist with a strong interest in understanding unconventional lymphocyte recognition, and wide experience in molecular and

    FIND OUT MORE

    Dr Carrie Willcox